Jingjing Wen
- Co-authors
- Mark GibsonJianda HuFang XuZi‐Xun YanDi FuLi WangWeili ZhaoTing Yang
- Topics
- Acute Myeloid Leukemia Research (9 papers)Multiple Myeloma Research and Treatments (6 papers)Protein Degradation and Inhibitors (6 papers)
- Cited by
- HematologyCancer ResearchPollution
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Jingjing Wen
37 papers receiving 236 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 104
- Oncology 64
- Cancer Research 43
- Hematology 33
- Health, Toxicology and Mutagenesis 32
Countries citing papers authored by Jingjing Wen
This map shows the geographic impact of Jingjing Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wen more than expected).
Fields of papers citing papers by Jingjing Wen
This network shows the impact of papers produced by Jingjing Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wen. The network helps show where Jingjing Wen may publish in the future.
Co-authorship network of co-authors of Jingjing Wen
This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Wen. A scholar is included among the top collaborators of Jingjing Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Wen. Jingjing Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 12 | |
| 10 | 3 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 24 | |
| 19 | 10 | |
| 20 | [Clinical outcome of 489 patients with diffuse large B-cell lymphoma and associated factors]. | 0 |
About Jingjing Wen
Jingjing Wen is a scholar working on Hematology, Transplantation and Pathology and Forensic Medicine, having authored 47 papers that have together received 239 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (33 citations), Cancer Research (43 citations) and Pollution (29 citations). Jingjing Wen has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Mark Gibson, Jianda Hu, Fang Xu, Zi‐Xun Yan, Di Fu, Li Wang, Weili Zhao, Ting Yang, Jiazheng Li and Pengpeng Xu. Their work appears in journals such as Blood, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.